Ian Pitfield
Chief Tech/Sci/R&D Officer bij GYROSCOPE THERAPEUTICS HOLDINGS PLC
Profiel
Ian Pitfield is a professional who has worked as the Head of Cell & Gene Therapy Medicine at GSK Plc from 1993 to 2016.
Currently, he is the Senior Vice President-Technical Operations at Gyroscope Therapeutics Holdings Plc since 2020.
Dr. Pitfield holds a doctorate degree from the University of Cambridge.
Actieve functies van Ian Pitfield
| Bedrijven | Functie | Begin |
|---|---|---|
| GYROSCOPE THERAPEUTICS HOLDINGS PLC | Chief Tech/Sci/R&D Officer | 01-07-2020 |
Eerdere bekende functies van Ian Pitfield
| Bedrijven | Functie | Einde |
|---|---|---|
| GSK PLC | Corporate Officer/Principal | 01-12-2016 |
Opleiding van Ian Pitfield
| University of Cambridge | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| GSK PLC | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Gyroscope Therapeutics Holdings Plc
 Gyroscope Therapeutics Holdings Plc BiotechnologyHealth Technology Gyroscope Therapeutics Holdings Plc engages in the development of gene therapy beyond rare diseases. It focuses on age-related macular degeneration. The company was founded in 2016 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
